Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. - Wikidata - awgldk - TriplyDB

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

http://www.wikidata.org/entity/Q43505948

about

Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review Clinical asthma phenotypes in the real world: opportunities and challenges Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran Bronchial thermoplasty in asthma: current perspectives Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysis Recent advances in the management of asthma using leukotriene modifiers The effects of zafirlukast on capsular contracture: preliminary report National Athletic Trainers' Association position statement: management of asthma in athletes.Recent advances: Respiratory medicine.Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Asthma, airway biology, and allergic rhinitis in AJRCCM 2000.Relationship between asthma drug therapy patterns and healthcare utilization.Management of asthma in adults: current therapy and future directions Combination therapy: appropriate for everyone?Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy.PILL Series. The 'problematic' asthma patient Severe asthma in children.Exhaled nitric oxide in paediatric asthma.The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Tolerance and rebound with zafirlukast in patients with persistent asthma The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1 Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Montelukast in guidelines and beyond.Asthma care practicing among general practitioners in Lebanon: a cross-sectional study Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma.Emerging interleukin receptor antagonists for the treatment of asthma.Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.Step 4: stick or twist? A review of asthma therapy.Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: a meta-analysis.

P2860

Q24197585-73A56A55-9FE5-47F1-B8A9-1B90A5142FDB Q24244152-7CF70610-371D-47DB-9207-DEED347B7B7C Q24245147-B4A12EA2-2A0F-4190-9F97-0D272B46CDAC Q24247489-C2991F49-C2FA-4E90-B634-A1B388795637 Q24794527-A7772006-B523-4181-85CB-BAB84E879821 Q26775236-090AA5A0-A5A2-466A-A12A-ACDB71314851 Q26777154-10BB1FB8-8B30-4F55-AA6C-996844B42072 Q26852643-89552D49-AD6F-42C8-B27D-181540C0F2BF Q26863510-197BE3EB-B48B-4859-92A7-BDF1AC9A5B19 Q28166742-782D94E1-640D-45B3-BDC0-3D5D29EDA0BA Q28263876-25345C67-7409-4CD6-9689-5409BFA4453F Q28769235-7946C37C-FCBD-4A1D-80EA-64D3CF2EEC60 Q33808282-C9425AC6-4E73-401C-A01F-380BE26E2D91 Q33877940-C468E52F-DF77-455F-90B9-A4EE51470AAA Q34424227-FA3A1D03-4E94-4EBF-891A-49934745EAF0 Q34446626-23BFBECA-A664-4767-9E91-47773B836C65 Q34579601-475F7293-9CE0-4957-9860-94805C53342C Q35143482-23DBD000-B287-4AD1-BC96-885707D2766D Q35180953-42F6AFCD-A089-40C9-BBCB-FAB13A798AFD Q35535752-790FD77B-7907-484C-B4B7-E58BBB56448F Q35535801-EFF86108-E041-423D-96AF-7482F1F6429A Q35577966-A9B3C330-6484-4918-9816-11A5D657C78B Q35779312-F72185F4-6883-4E52-B85E-EC461BCF4547 Q35879047-6D4B4A97-5CF4-446A-86AF-682CF487AB6A Q35905019-67482FF6-0BDF-4BB2-B6B8-706CA656F572 Q36108246-40E2A192-A4D1-4560-A8F5-5F454E619B87 Q36310751-83C3CBA7-6136-4E34-BCD5-F37D75A1272A Q36422663-25F5BF5F-9AB1-402D-AEB8-9F7A12D91D6E Q36566081-0ABDBFA9-9118-40A9-BC1E-6EC1CA015679 Q36717710-C797D076-D678-4847-936A-117DD850E54B Q36929333-C19F2464-C08B-49D6-8F4B-065785E8E2CA Q36954589-4D2F2768-0167-48DA-A0D4-4D5125AAC80E Q37522916-C1D7B5BC-DEE3-4B72-B297-2F4DCCB279AA Q37534372-4FDEC19C-5D62-4322-835F-31EE6829796F Q37552495-12E230C5-9719-4A4D-B248-5270ED32FA25 Q38091461-500F6734-4BC9-4FAE-82F8-36DE98FF0CCF Q38638355-A4A28EC9-1BAC-43D3-8719-E4678812B224 Q38903489-9493ED4B-75E6-4385-988F-D11EB85EB1F8 Q38960423-80BCF25A-0248-46EA-9DB2-A9F78C7F83D2 Q40253047-54EEFB60-3F74-4C18-8915-8A7FF3D07BEB

P2860

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

http://www.wikidata.org/entity/Q43505948

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@en

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@nl

type

label

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@en

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@nl

prefLabel

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@en

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@nl

P1433

Q43505948-943A89B1-804C-49C1-8387-B0DF2FFBC724

P1476

Q43505948-BC6D683A-B52D-4B6E-BBF9-567FBA5D98AF

P2093

Q43505948-2ACB24CC-8CB6-481C-905A-87FA2AA78417

Q43505948-447F43A1-C38B-47BF-8926-1B5D533D2BB9

Q43505948-97D50EAF-1E98-482D-9CA3-7409C4AB6B3C

Q43505948-E500D3E4-BDA5-4871-B61A-EF675E6AC16E

Q43505948-FC64FA96-5EB2-40F1-8B25-AB3E11C95913

P2860

Q43505948-0C4FBE42-B1A5-46A0-976A-7C33FC0DFEFD

Q43505948-218C9794-E858-488B-961C-57F4E64612E5

Q43505948-2CCCD640-913E-47F3-A165-353D436A7FF8

Q43505948-5E01E8A2-6439-418E-B112-77E96EA433D0

Q43505948-75F31447-63D7-4CF7-9144-78F610DD53F0

Q43505948-7EDDC232-D63A-4F71-B0A0-C71369900F9A

Q43505948-8C676A76-8A0B-434B-94B5-9C88BA2EA16E

Q43505948-A361F733-5556-4F2A-A2A2-87D4C9BC0870

Q43505948-B411CEF4-9752-4093-91EB-0718BFD1047D

Q43505948-B5FFC3A7-4FE9-42BF-BF71-DB8C64DE3E55

P304

Q43505948-047F1AFE-8FF8-4629-8350-07BCE09D4AF8

P31

Q43505948-B28F274A-1328-449B-8E33-9E787F3415E6

P356

Q43505948-1C9EB856-1311-42FF-9A9F-03E093D1CD86

P407

Q43505948-0CE28802-8B01-45A4-8EAF-C9B90C30039F

P433

Q43505948-37A1440A-78B7-4F64-A4AF-27AE75BD6715

P478

Q43505948-26EE3714-7577-49D0-A8F9-28659F06A035

P577

Q43505948-C7424894-465F-47F8-A04E-BD66AEE6A2FE

P698

Q43505948-0A702735-7A64-4EDB-A7A1-997B07009603

P921

Q43505948-F4809BC9-A06D-44AD-81F8-9311CEA69E39

P356

AJRCCM.162.2.9905041

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.

@en

P2093

A Harris

http://www.w3.org/2001/XMLSchema#string

A Prasse

http://www.w3.org/2001/XMLSchema#string

I Naya

http://www.w3.org/2001/XMLSchema#string

J C Virchow

http://www.w3.org/2001/XMLSchema#string

L Summerton

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.

P304

578-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.162.2.9905041

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10934090

http://www.w3.org/2001/XMLSchema#string

P921